...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Immunotherapy for Cancer

I would love some liquidity AFTER they do a big deal that puts money in everyone's pockets. 

Share
New Message
Please login to post a reply